Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current aspects of Shigella pathogenesis.

Alfredo G Torres1

  • 1Department of Microbiology and Immunology, Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas 77555-1070, USA. altorres@utmb.edu

Revista Latinoamericana De Microbiologia
|October 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Escherichia coli</i> and <i>Salmonella</i>: their past, present, and future in scientific research and publications.

Microbiology and molecular biology reviews : MMBR·2026
Same author

Antibodies to <i>Burkholderia pseudomallei</i> Outer Membrane Proteins Coupled to Nanovaccines Exhibit Cross-Reactivity to <i>B. cepacia</i> Complex and <i>Pseudomonas aeruginosa</i> Homologues.

Microorganisms·2026
Same author

Stress granule component TIA-1 is a negative regulator of the non-canonical NLRP3 inflammasome.

bioRxiv : the preprint server for biology·2025
Same author

Evaluation of highly conserved Burkholderia pseudomallei outer membrane proteins as protective antigens against respiratory melioidosis.

NPJ vaccines·2025
Same author

Glanders: An ancient and emergent disease with no vaccine or treatment on site.

PLoS neglected tropical diseases·2025
Same author

Evaluation of Highly Conserved <i>Burkholderia pseudomallei</i> Outer Membrane Proteins as Protective Antigens Against Respiratory Melioidosis.

Research square·2025

Bacillary dysentery, or shigellosis, is a severe illness caused by Shigella bacteria. This review details factors influencing shigellosis pathogenesis and discusses progress in vaccine development.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Bacillary dysentery (shigellosis) is a significant human health concern caused by Shigella.
  • Recent research has elucidated host, pathogen, and environmental factors in shigellosis pathogenesis at cellular and molecular levels.

Purpose of the Study:

  • To review current knowledge on Shigella and its pathogenesis.
  • To examine factors contributing to shigellosis development.
  • To assess progress in developing a shigellosis vaccine.

Main Methods:

  • Literature review of cellular and molecular studies on shigellosis.
  • Analysis of host-pathogen interactions.
  • Examination of vaccine development research.

Related Experiment Videos

Main Results:

  • Detailed understanding of Shigella virulence factors.
  • Identification of key host responses to infection.
  • Overview of challenges and advancements in vaccine design.

Conclusions:

  • Shigella pathogenesis is multifactorial, involving complex host-pathogen interactions.
  • Vaccine development for shigellosis is ongoing, with promising avenues being explored.